Novel Oral Anticoagulant Fast Tracked for Patients With ESRD and Atrial Fibrillation
Tecarfarin is a novel oral vitamin K antagonist with a similar mechanism of action to warfarin, though it is metabolized differently.
Diagnosis & Disease Information
FDA Approves Wearable Furosemide Delivery System Furoscix for Outpatient Use
Furoscix is a pH-neutral formulation of furosemide designed for SC administration via a wearable, single-use, pre-programmed on-body infusor for outpatient self-administration.
Heart Failure Hospitalization Risk Compared With Empagliflozin vs Other Glucose-Lowering Tx
The EMPRISE study assessed the efficacy and safety of empagliflozin use in approximately 500,000 adults with type 2 diabetes.
FDA to Review Wearable Furosemide Delivery System for Outpatient Use
Furoscix is a wearable, pre-programmed on-body furosemide delivery system for outpatient self-administration.
CaroSpir, a Liquid Form of Spironolactone, Now Available in Unit Dose Cups
The new packaging allows for ease of administration and convenience.
Heart Failure With Mildly Reduced Ejection Fraction: Treatment Options Explored
Despite an increasing emphasis on HFmrEF over the past several years, there is a lack of authoritative guidance surrounding therapeutic approaches for these patients.
Mixed Results for Omecamtiv Mecarbil in Heart Failure Study
Findings showed the study met the primary end point of reduction in cardiovascular death or heart failure events.
- Loading...
Loading...
Next post in Hypertension
Loading... 
Loading...